Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/23/2014US8916610 Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
12/23/2014US8916609 Compounds as L-cystine crystallization inhibitors and uses thereof
12/23/2014US8916607 Use of piperphentonamine or salts thereof in manufacture of medicaments for treating brain diseases
12/23/2014US8916606 Therapeutic compositions and methods for targeted delivery of active agents
12/23/2014US8916605 Compounds and methods for treating cancer and viral infections
12/23/2014US8916604 Compositions and methods for epigenetic modification of nucleic acid sequences
12/23/2014US8916603 Methods for treatment with bucindolol based on genetic targeting
12/23/2014US8916602 Fusarisetin compounds, and use thereof
12/23/2014US8916601 Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides
12/23/2014US8916600 Phenyl and benzodioxinyl substituted indazoles derivatives
12/23/2014US8916599 1H-benz imidazole-5-carboxamides as anti-inflammatory agents
12/23/2014US8916598 Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
12/23/2014US8916596 Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor
12/23/2014US8916594 5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity
12/23/2014US8916593 Alkoxy-substituted 2-aminopyridines as ALK inhibitors
12/23/2014US8916592 Malononitrile compounds
12/23/2014US8916591 Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
12/23/2014US8916590 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
12/23/2014US8916589 Bradykinin B1-antagonists
12/23/2014US8916588 Methods for treatment of attention deficit hyperactivity disorder
12/23/2014US8916587 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
12/23/2014US8916586 Anti-angiogenic compound
12/23/2014US8916585 Nitrogen-containing heteroaryl compounds and methods of use thereof
12/23/2014US8916584 Benzisoxazoles and azabenzisoxazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
12/23/2014US8916583 Therapeutic compositions for intranasal administration of zolpidem
12/23/2014US8916582 Morphinan compounds
12/23/2014US8916581 (S)-N-methylnaltrexone
12/23/2014US8916580 Spiro-oxindole compounds and their use as therapeutic agents
12/23/2014US8916578 Pesticidal pyrimidine compounds
12/23/2014US8916577 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
12/23/2014US8916576 Pharmacokinetically improved compounds
12/23/2014US8916574 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors
12/23/2014US8916573 Quinazoline-2,4-dione derivatives
12/23/2014US8916572 Bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinase
12/23/2014US8916571 Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase
12/23/2014US8916570 A3 adenosine receptor agonists and antagonists
12/23/2014US8916569 Compounds and methods for inhibiting phosphate transport
12/23/2014US8916568 Method of using diketopiperazines and composition containing them
12/23/2014US8916567 Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof
12/23/2014US8916566 Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
12/23/2014US8916565 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
12/23/2014US8916564 Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
12/23/2014US8916563 Aldose reductase inhibitors and uses thereof
12/23/2014US8916562 Methods and compositions for safe and effective treatment of telangiectasia
12/23/2014US8916561 Substituted quinoxaline compounds for the inhibition of PASK
12/23/2014US8916560 Heterocyclic compounds for the inhibition of PASK
12/23/2014US8916559 Crystalline compound of 7-[(3R)-3-amino-1-oxo-4-(2, 4, 5-trifluorophenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluoromethyl)-1, 2, 4 -triazolo[4,3-A]pyrazin
12/23/2014US8916558 Powders for reconstitution
12/23/2014US8916556 Pharmaceutical formulations comprising neurotrophin mimetics
12/23/2014US8916555 3,5-diaminopyrazole kinase inhibitors
12/23/2014US8916554 Amino-derivatives as novel inhibitors of histone deacetylase
12/23/2014US8916552 Pharmaceutical combinations
12/23/2014US8916550 Compounds for modulating TRPV3 function
12/23/2014US8916549 Thienooxazepine derivative
12/23/2014US8916546 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
12/23/2014US8916545 Pharmaceutical compositions comprising POH derivatives
12/23/2014US8916544 Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
12/23/2014US8916543 Inhibitors of alpha-toxin
12/23/2014US8916542 Chitosan derivatives, compositions and related methods of use
12/23/2014US8916541 Synergistic combination of honokiol and modified citrus pectin in cancer therapy
12/23/2014US8916540 Antibiotic compositions and related screening methods
12/23/2014US8916539 Use of lipid conjugates in the treatment of disease
12/23/2014US8916538 Solid forms of a thiophosphoramidate nucleotide prodrug
12/23/2014US8916536 Bone-targeting bisphosphonate duplex drugs
12/23/2014US8916535 Use of 2′,5′-oligoadenylate derivative compounds
12/23/2014US8916534 Methods of inducing insulin production
12/23/2014US8916530 Individualized cancer therapy
12/23/2014US8916529 Oligonucleotide-containing pharmacological compositions and their use
12/23/2014US8916528 Compositions containing resveratrol and nucleotides
12/23/2014US8916527 Antibiotic macrocycle compounds and methods of manufacture and use thereof
12/23/2014US8916526 Flavanone derivative
12/23/2014US8916378 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
12/23/2014US8916211 Method and composition for preventing and treating avian influenza in poultry
12/23/2014US8916206 Nanoparticles containing water-soluble non-peptide low-molecular weight drug
12/23/2014US8916203 Stable formulations for lyophilizing therapeutic particles
12/23/2014US8916202 Floating microgranules
12/23/2014US8916201 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
12/23/2014US8916196 Method for the production of emulsion-based microparticles
12/23/2014US8916195 Sustained release formulation of naltrexone
12/23/2014US8916194 Controlled release pharmaceutical compositions of milnacipran
12/23/2014US8916193 Rifaximin complexes
12/23/2014US8916191 Device for transdermal administration of drugs including acrylic polymers
12/23/2014US8916171 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
12/23/2014US8916147 Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
12/23/2014US8916143 Polymer compositions of dihydroxyacetone and uses thereof
12/23/2014US8916142 Semi-crystalline supramolecular polymers
12/23/2014US8916141 Hyaluronidase inhibitor containing poly-gamma-glutamic acid as an effective component
12/23/2014US8916136 Glucose biosensor system coupled with an anti-inflammatory module and methods for using the same
12/23/2014US8916132 Benzimidazole-derived compounds use as markers in the case of neurodegenerative diseases
12/18/2014US20140373188 Compositions for rna interference and methods of use thereof
12/18/2014US20140371717 Drug delivery medical device
12/18/2014US20140371693 Adhesive preparation
12/18/2014US20140371491 Diarylalkanes as potent inhibitors of binuclear enzymes
12/18/2014US20140371432 Novel oligonucleotide conjugates and use thereof
12/18/2014US20140371329 Buffered Oxygen Therapeutic
12/18/2014US20140371327 Formulation of Curcumin with Enhanced Bioavailability of Curcumin and method of preparation and treatment thereof
12/18/2014US20140371326 Food composition for preventing obesity, pharmaceutical composition for treating obesity, and animal medicine for treating obesity, containing gingernone a
12/18/2014US20140371325 Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
12/18/2014US20140371323 Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
12/18/2014US20140371322 Phenoxybenzamine Transdermal Composition
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 7860